Ask AI
Bill104th CongressFiled Jun 6, 1996Health
H.Res. 449

Relating to breast implants, the Food and Drug Administration, and breast care.

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in house (Jun 6, 1996)

Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.

What just happenedJun 14, 1996

Referred to the Subcommittee on Health and Environment.

Who’s behind it

Rep. Vucanovich, Barbara F. [R-NV-2](R-NV)Sponsor
20 cosponsors8 D12 R
Read on Congress.gov
20cosponsors1committees5actions14subjects
  1. Jun 14, 1996CommitteeH11000

    Referred to the Subcommittee on Health and Environment.

    Health and Environment Subcommittee
  2. Jun 7, 1996IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1032-1033)

  3. Jun 6, 1996IntroReferralH11100

    Referred to the House Committee on Commerce.

    Energy and Commerce Committee
  4. Jun 6, 1996IntroReferralIntro-H

    Introduced in House

  5. Jun 6, 1996IntroReferral1000

    Introduced in House